Web-based patient survey on current status of goal setting and relationships between objective evaluable goal setting and patients' perceptions in treatment of depressio
Not Applicable
- Conditions
- Major depressive disorder (MDD)
- Registration Number
- JPRN-UMIN000050370
- Lead Sponsor
- Takeda Pharmaceutical Company Limited.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
- Suicide attempts: top 2 choices ("more than half of the time", "almost every day") on a 4-point scale for item (I) of the PHQ-9 - Those who can understand Japanese - Those with no MDD practice codes (ICD10 codes: F32-F33) in claims data from February 1, 2022 to August 31, 2022.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Goal setting in depression treatment or not
- Secondary Outcome Measures
Name Time Method '- SMARTness of the established goals - Correlation between SMART level of the goal or each SMART factor and the trust relationship with the physician, subjective evaluation of the goal, and satisfaction with the treatment.